Brentuximab Vedotin Injection

Brentuximab Vedotin Injection is a topic covered in the Consumer DrugInfo.

To view the entire topic, please or purchase a subscription.

Explore these free sample topics:

-- The first section of this topic is shown below --

General

Pronunciation:
(bren tux' i mab ve doe' tin)

Brand name:

  • Adcetris®

Important Warning

Receiving brentuximab vedotin injection may increase the risk that you will develop progressive multifocal leukoencephalopathy (PML; a rare infection of the brain that cannot be treated, prevented, or cured and that usually causes death or severe disability). Tell your doctor if you have or have ever had a condition that affects your immune system. Tell your doctor and pharmacist if you are taking any medications that suppress the immune system. If you experience any of the following symptoms, stop receiving brentuximab vedotin injection and call your doctor immediately: decreased strength or weakness on one side of the body; difficulty walking; loss of coordination; headache; confusion; difficulty thinking clearly; memory loss; changes in mood or usual behavior; difficulty speaking; or vision problems.

Keep all appointments with your doctor and the laboratory. Your doctor may order certain tests to check your body's response to brentuximab vedotin injection.

Talk to your doctor about the risks of receiving brentuximab vedotin injection.

-- To view the remaining sections of this topic, please or purchase a subscription --

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Brentuximab Vedotin Injection ID - 113145 PB - Consumer DrugInfo UR - http://familydrugguide.com/family/view/Consumer_DrugInfo/113145/all/Brentuximab_Vedotin_Injection ER -